Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Innovent Biologics logo

Innovent Biologics

Recent Finacing

Series E

Recent Raise

$150M

Innovent Biologics is a Shanghai-based biopharmaceutical company developing and manufacturing complex antibody biologics for oncology, ophthalmology, autoimmune and cardiovascular indications, with cGMP facilities compliant with CFDA, FDA and EMA standards.

Founded 2011
Jiangsu, China
5K-10K
Publicly Traded
innoventbio.com

Highlights

Focus Areas

Biopharma
Biotechnology
Manufacturing

Recent Investors

Legend Capital logo
Temasek logo
Taikang logo
Lilly Asia Ventures logo
Milestone logo
国寿股权 logo
SDIC Fund logo
H
Ping An logo
Ally Bridge Group logo
Cormorant Asset Management logo
Capital Group Private Markets logo

Financials

$510M

Total Raised

3

Funding rounds

17

Investors


Team

Upgrade to view the team

See the team members at Innovent Biologics.